Notably, an opposite correlation was observed in BC patients with less aggressive grades I and II (Supplementary Figure S4), suggesting that ANXA9 regulation of breast cancer may be related with the tumor aggressiveness and cancer progression. The gene discussed is ANXA9; the disease is breast carcinoma.